Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification.

MLA

Bulik-Sullivan, Brendan, et al. “Deep Learning Using Tumor HLA Peptide Mass Spectrometry Datasets Improves Neoantigen Identification.” Nature Biotechnology, vol. 37, no. 1, Jan. 2019, pp. 55–63. EBSCOhost, https://doi.org/10.1038/nbt.4313.

APA

Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., Ojo, N. C., Caldwell, K., Abhyankar, J., Boucher, T., Hart, M. G., Makarov, V., De Montpreville, V. T., Mercier, O., Chan, T. A., & Scagliotti, G. (2019). Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification. Nature Biotechnology, 37(1), 55–63. https://doi.org/10.1038/nbt.4313

Chicago

Bulik-Sullivan, Brendan, Jennifer Busby, Christine D Palmer, Matthew J Davis, Tyler Murphy, Andrew Clark, Michele Busby, et al. 2019. “Deep Learning Using Tumor HLA Peptide Mass Spectrometry Datasets Improves Neoantigen Identification.” Nature Biotechnology 37 (1): 55–63. doi:10.1038/nbt.4313.